Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice1
Martin Drage(University of Cambridge), Anne Cooke(Wellcome Trust), Jenny M. Phillips(University of Catania), J. Andrew Bradley(University of Cambridge), Ferdinando Nicoletti(University of Catania), Paola Zaccone(University of Catania), Janet Dawson(Novartis (Switzerland))
Cited by 27
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508